| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/10/2004 | US6689121 Systems and methods for treating ischemia |
| 02/10/2004 | US6689117 Drug delivery system for implantable medical device |
| 02/10/2004 | US6689100 Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
| 02/10/2004 | US6688497 Apparatus and method for tissue rinse |
| 02/10/2004 | US6688304 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 02/10/2004 | CA2372576C Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 02/10/2004 | CA2359812C Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| 02/10/2004 | CA2307370C Method for producing a powder from a liquid substance or mixture of substances |
| 02/10/2004 | CA2229597C Oral fast-dissolving compositions for dopamine agonists |
| 02/10/2004 | CA2145631C Two-phase matrix for sustained release drug delivery device |
| 02/10/2004 | CA2134196C Pharmaceutical preparation and process for its manufacture |
| 02/10/2004 | CA2109053C Stabilised hexadecylphosphocholine solutions in glycerol alkyl ethers |
| 02/10/2004 | CA2101697C Controlled release potassium chloride tablet |
| 02/10/2004 | CA2079447C Sustained drug release through topical application of bioadhesive liposomes |
| 02/10/2004 | CA2070061C Physiologically active polypeptide-containing pharmaceutical composition |
| 02/10/2004 | CA2054955C Cosmetic, pharmaceutic or food composition comprising a lipid vesicles dispersion |
| 02/09/2004 | CA2398828A1 A pharmaceutical composition containing an indolopyrrolocarbazole derivative |
| 02/07/2004 | CA2395931A1 Solid compositions comprising gabapentin having improved stability |
| 02/05/2004 | WO2004011432A1 Organic acid salt of amlodipine |
| 02/05/2004 | WO2004011416A1 CRYSTALLINE β2 ADRENERGIC RECEPTOR AGONIST |
| 02/05/2004 | WO2004011368A2 Low temperature anodic bonding method using focused energy for assembly of micromachined systems |
| 02/05/2004 | WO2004011062A1 Administration device comprising an osmotic drive |
| 02/05/2004 | WO2004011055A2 Implantable or insertable medical devices for controlled drug delivery |
| 02/05/2004 | WO2004011054A2 Injectable multimodal polymer depot compositions and uses thereof |
| 02/05/2004 | WO2004011035A2 Bio-degradable microspheres for diagnosing gastroesophagal reflux |
| 02/05/2004 | WO2004011032A1 External preparation |
| 02/05/2004 | WO2004011023A1 Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin |
| 02/05/2004 | WO2004011006A1 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 02/05/2004 | WO2004011004A1 Formulation of liposomal derivatives of phenylalanine |
| 02/05/2004 | WO2004011002A1 Sustained-release tablet composition comprising a dopamine receptor agonist |
| 02/05/2004 | WO2004011001A1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 02/05/2004 | WO2004010999A1 Pramipexole once-daily dosage form |
| 02/05/2004 | WO2004010998A1 Sustained-release tablet comprising reboxetine |
| 02/05/2004 | WO2004010997A1 Sustained-release tablet composition of pramipexole |
| 02/05/2004 | WO2004010994A1 Indometacin preparation for external use |
| 02/05/2004 | WO2004010993A1 Composition comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent |
| 02/05/2004 | WO2004010988A1 Percutaneous and perungual delivery system |
| 02/05/2004 | WO2004010984A2 Microcapsules with modified release of active principles with low solubility for oral delivery |
| 02/05/2004 | WO2004010983A2 Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility |
| 02/05/2004 | WO2004010982A1 Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former |
| 02/05/2004 | WO2004010981A1 Methods and dosage forms for controlled delivery of paliperidone |
| 02/05/2004 | WO2004010980A1 Compositions comprising hmg-coa reductase inhibitor |
| 02/05/2004 | WO2004010979A1 Processes for the preparation of oral dosage formulations of modafinil |
| 02/05/2004 | WO2004010978A1 Multicomponent pharmaceutical dosage form |
| 02/05/2004 | WO2004010977A1 Method for decreasing bioavailability variability of an orally administered medicine |
| 02/05/2004 | WO2004010976A1 Solid dispersion comprising amlodipine, method thereof and pharmaceutical composition comprising the solid dispersion |
| 02/05/2004 | WO2004010975A2 Controlled drug delivery |
| 02/05/2004 | WO2004010974A2 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | WO2004010973A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | WO2004010972A2 Pellicle-resistant gelatin capsule |
| 02/05/2004 | WO2004010971A1 Implantable mems medicine delivery system |
| 02/05/2004 | WO2004010970A1 Formulations and dosage forms for controlled delivery of topiramate |
| 02/05/2004 | WO2004010969A1 Chinese herb medicine composition in the form of jelly |
| 02/05/2004 | WO2004010952A2 Methods and compositions for treatment of dermal conditions |
| 02/05/2004 | WO2004010944A2 Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications |
| 02/05/2004 | WO2004010941A2 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 02/05/2004 | WO2004010934A2 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 02/05/2004 | WO2004010916A1 Labial product system to maintain a treatment agent |
| 02/05/2004 | WO2004010894A2 Ophthalmologic irrigation solutions and method |
| 02/05/2004 | WO2004010842A2 Lipophilic electrophoretic probes |
| 02/05/2004 | WO2004010796A1 Gel-type drink composition |
| 02/05/2004 | WO2003099197A3 Formulations of erythromycin derivatives with improved bioavailability |
| 02/05/2004 | WO2003096968A3 Oral osmotic controlled drug delivery system |
| 02/05/2004 | WO2003094898A3 Microcapsules containing biomedical materials |
| 02/05/2004 | WO2003089001A8 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus |
| 02/05/2004 | WO2003087159A3 Modulators of the notch signalling pathway and uses thereof in medical treatment |
| 02/05/2004 | WO2003087049A3 Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent |
| 02/05/2004 | WO2003086293A3 Pharmaceutical preparation for taste masking |
| 02/05/2004 | WO2003084938A3 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases |
| 02/05/2004 | WO2003082915A3 Xcrf polynucleotides and polypeptides and uses thereof |
| 02/05/2004 | WO2003082247A3 Drug microparticles |
| 02/05/2004 | WO2003082244A3 Hfa-suspension formulation of an anhydrate |
| 02/05/2004 | WO2003080181A3 Storage stable eplerenone formulation |
| 02/05/2004 | WO2003072020A3 Therapeutical polyanhydride compounds for drug delivery |
| 02/05/2004 | WO2003070214A3 Method of automatically populating contact information fields for a new contact added to an electronic contact database |
| 02/05/2004 | WO2003002710A3 Artificial synapse chip interface for electronic prosthetic retina |
| 02/05/2004 | WO2002098477A3 Bioactive surface modifiers for polymers and articles made therefrom |
| 02/05/2004 | WO2002072150A3 Micellar drug delivery vehicles and uses thereof |
| 02/05/2004 | US20040024450 Drug-delivery endovascular stent and method for treating restenosis |
| 02/05/2004 | US20040024382 Medicine delivery system |
| 02/05/2004 | US20040024179 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 02/05/2004 | US20040024096 Dual stimuli-responsive hydrogels and their synthetic methods |
| 02/05/2004 | US20040024069 A biodegradable, biocompatible polymer, a water-immiscible solvent to plasticize the polymer and form a gel, a thixotropic agent and a beneficial agent; drug delivery; improved shear thinning and reduced injection |
| 02/05/2004 | US20040024061 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 02/05/2004 | US20040024056 Especially Cryptotanshinone and Dihydortanshinone; treatment of chronic hepatitis and hepatocirrhosis |
| 02/05/2004 | US20040024041 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 02/05/2004 | US20040024036 May take form of gel, ointment or emulsion for local administration, of transdermal patch or of film deposited by a spray, characterized in that it comprises at least one absorption promoter |
| 02/05/2004 | US20040024028 Comprises gradual decreases in nicotine dosage via transdermal patch |
| 02/05/2004 | US20040024025 Compositions and methods for inducing cell death |
| 02/05/2004 | US20040024018 Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 02/05/2004 | US20040024006 Opioid agonist analgesic, a neutral receptor binding agent and a carrier |
| 02/05/2004 | US20040024003 Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy |
| 02/05/2004 | US20040023987 Sustained release compositions |
| 02/05/2004 | US20040023948 Fast-dispersing dosage form containing 5-HT1 agonists |
| 02/05/2004 | US20040023923 Beta -Glucan which is cold-water soluble and is capable of forming a gel. The solubility is greater than 2% by weight in water at a temperature below approximately 50 degrees C. A process for preparing the beta -glucan by recovering the |
| 02/05/2004 | US20040023922 Lipids for modulating immune response |
| 02/05/2004 | US20040023911 Delivering a naked or isolated polynucleotide to the interior of a cell in a vertebrate, comprising the interstitial introduction of a naked polynucleotide into a tissue of the vertebrate where the polynucleotide is taken up by the cells |
| 02/05/2004 | US20040023899 Extending the release times and lowering the toxicity of pharmacologically active compounds. The compounds comprise a salt of the pharmacologically active compound with a lipophilic counterion and a pharmaceutically acceptable water |
| 02/05/2004 | US20040023893 Coumarin derivatives for treatment of vascular disorders, skin disorders or allergies |
| 02/05/2004 | US20040023892 Pharmaceutical composition based on a non-steroid anti-inflammatory agent |